78 related articles for article (PubMed ID: 6945040)
1. HLA-DR antigen linkage in hypertrophic cardiomyopathy.
Becque O; Herve P; Bassand JP; Bernard Y; Maurat JP
Am Heart J; 1981 Oct; 102(4):806-8. PubMed ID: 6945040
[No Abstract] [Full Text] [Related]
2. HLA antigen associations in hypertrophic cardiomyopathy.
Mourant AJ; Kafetz KM; Brigden WW; Awad J; D'Amaro J; Yeatman NW; Festenstein H
Tissue Antigens; 1982 Nov; 20(5):389-93. PubMed ID: 6818713
[TBL] [Abstract][Full Text] [Related]
3. [Occurrence of HLA-antigens in patients with hypertrophic cardiomyopathy].
Bodem R; Zipperle S; Ho A; Lenhard V
Z Kardiol; 1982 Dec; 71(12):820-3. PubMed ID: 6962579
[TBL] [Abstract][Full Text] [Related]
4. HLA-DR3 antigen linkage in patients with hypertrophic obstructive cardiomyopathy.
Fiorito S; Autore C; Fragola PV; Purpura M; Cannata D; Sangiorgi M
Am Heart J; 1986 Jan; 111(1):91-4. PubMed ID: 3484891
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRW4 antigen linkage in patients with hypertrophic obstructive cardiomyopathy.
Matsumori A; Kawai C; Wakabayashi A; Terasaki PI; Park MS; Sakurami T; Ueno Y
Am Heart J; 1981 Jan; 101(1):14-6. PubMed ID: 6161533
[TBL] [Abstract][Full Text] [Related]
6. Human lymphocyte antigens in hypertrophic cardiomyopathy.
Zezulka A; MacKintosh P; Jobson S; Lowry P; Shapiro LM
Int J Cardiol; 1986 Aug; 12(2):193-202. PubMed ID: 3462161
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR2 antigen linkage in patients with apical hypertrophic cardiomyopathy in Japan.
Kishimoto C; Takada H; Hiraoka Y; Suzaki M; Maruya E; Tomioka N
Cardiology; 1996; 87(6):488-91. PubMed ID: 8904675
[TBL] [Abstract][Full Text] [Related]
8. [HLA-DRW grouping in obstructive myocardiopathy].
Becqué O; Bernard Y; Bassand JP; Hervé P; Maurat JP
Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1359-62. PubMed ID: 6439160
[TBL] [Abstract][Full Text] [Related]
9. [Genetic aspects of hypertrophic cardiomyopathy (familial studies and relation of HLA to obstructive hypertrophic cardiomyopathy)].
Moiseev VS; Polianskaia IS; Iazdovskiĭ VV; Korovina EP; Guniia MG
Ter Arkh; 1987; 59(8):82-5. PubMed ID: 3500526
[TBL] [Abstract][Full Text] [Related]
10. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.
Shichi D; Kikkawa EF; Ota M; Katsuyama Y; Kimura A; Matsumori A; Kulski JK; Naruse TK; Inoko H
Tissue Antigens; 2005 Sep; 66(3):200-8. PubMed ID: 16101831
[TBL] [Abstract][Full Text] [Related]
11. An immunogenetic study in hypertrophic cardiomyopathy.
Gregor P; Ivasková E; Sajdlová H; Kupková L; Widimský P; Cervenka V
Cor Vasa; 1991; 33(5):414-23. PubMed ID: 1810702
[TBL] [Abstract][Full Text] [Related]
12. DR and non-DR Ia allotypes are associated with susceptibility to coeliac disease.
Corazza GR; Tabacchi P; Frisoni M; Prati C; Gasbarrini G
Gut; 1985 Nov; 26(11):1210-3. PubMed ID: 3877664
[TBL] [Abstract][Full Text] [Related]
13. HLA in hypertrophic cardiomyopathy and rheumatic heart disease.
Matsumori A; Hirose K; Wakabayashi A; Kawai C; Nabeya N; Sakurami T; Tsuji K
Jpn Circ J; 1979 May; 43(5):445-9. PubMed ID: 572881
[TBL] [Abstract][Full Text] [Related]
14. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
[TBL] [Abstract][Full Text] [Related]
15. [The human histocompatibility complex in hypertrophic cardiomyopathy].
Pasalodos Pita J; Sancho Jaldón M; Trapiello González L; Grilo Reina A; Pareja Tallo E; Garrido Torrespuchol F; Vallés Belsue F
Rev Esp Cardiol; 1981; 34(5):389-93. PubMed ID: 7199198
[No Abstract] [Full Text] [Related]
16. HLA-DR matching: the impact on cadaveric renal transplantation. A single-center study.
Madsen M; Graugaard B; Fjeldborg O; Posborg V; Hansen HE; Lamm LU; Kissmeyer-Nielsen F
Scand J Urol Nephrol Suppl; 1981; 64():56-63. PubMed ID: 6815794
[No Abstract] [Full Text] [Related]
17. [HLA antigens in patients with primary cardiomyopathy].
Pietrzak M; Zebrowski A; Krzemińska-Pakuła M; Kaczmarek A; Miś J
Kardiol Pol; 1988; 31(9):598-604. PubMed ID: 3244236
[No Abstract] [Full Text] [Related]
18. Hypertrophic cardiomyopathy and HLA.
Bloch A; Crittin J; Barras C; Jeannet M
N Engl J Med; 1980 May; 302(18):1033. PubMed ID: 7189243
[No Abstract] [Full Text] [Related]
19. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
Whiteside TL; Medsger TA; Rodnan GP
J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
[TBL] [Abstract][Full Text] [Related]
20. [Expression of HLA-DR antigen in cutaneous malignant lymphomas and recombinant gamma interferon induces HLA-DR antigen on cultured human keratinocytes].
Kameyama K; Tone T; Eto H; Takezaki S
Nihon Hifuka Gakkai Zasshi; 1986 Apr; 96(5):483-91. PubMed ID: 2426482
[No Abstract] [Full Text] [Related]
[Next] [New Search]
